Comments on: Rosiglitazone increases CV events http://www.prescriber.org.uk/2007/05/rosiglitazone-increases-cv-events/ An NHS Prescribing Advisers' Blog Mon, 06 Feb 2012 12:49:30 +0000 hourly 1 http://wordpress.org/?v=3.3.1 By: Prescribing Advice for GPs » New RECORD but same tune http://www.prescriber.org.uk/2007/05/rosiglitazone-increases-cv-events/comment-page-1/#comment-3447 Prescribing Advice for GPs » New RECORD but same tune Mon, 22 Jun 2009 09:42:03 +0000 http://www.prescriber.org.uk/?p=369#comment-3447 [...] known. Glitazones increase the risk of heart failure and fractures. Rosiglitazone has also been suspected of increasing the risk of heart attacks and while this study indicates no increased risk of [...] [...] known. Glitazones increase the risk of heart failure and fractures. Rosiglitazone has also been suspected of increasing the risk of heart attacks and while this study indicates no increased risk of [...]

]]> By: Increases In Blood Pressure http://www.prescriber.org.uk/2007/05/rosiglitazone-increases-cv-events/comment-page-1/#comment-2415 Increases In Blood Pressure Mon, 04 Feb 2008 01:30:10 +0000 http://www.prescriber.org.uk/?p=369#comment-2415 <strong>Blood Pressure and Weight Loss</strong> Over weight is a common cause to a number of problems. There are a number of people who are facing the problem of over weight and obesity. Blood Pressure and Weight Loss

Over weight is a common cause to a number of problems. There are a number of people who are facing the problem of over weight and obesity.

]]> By: adr.org.uk » Blog Archive » Rosiglitazone (Avandia) and cardiovascular events http://www.prescriber.org.uk/2007/05/rosiglitazone-increases-cv-events/comment-page-1/#comment-1569 adr.org.uk » Blog Archive » Rosiglitazone (Avandia) and cardiovascular events Wed, 20 Jun 2007 08:34:39 +0000 http://www.prescriber.org.uk/?p=369#comment-1569 [...] Over the past month the New England Journal of Medicine has published a meta-analysis and an interim results paper of the RECORD study concerned with the cardiovascular safety of rosiglitazone. There is coverage of both the meta-analysis and the trial data at prescriber.org.uk. [...] [...] Over the past month the New England Journal of Medicine has published a meta-analysis and an interim results paper of the RECORD study concerned with the cardiovascular safety of rosiglitazone. There is coverage of both the meta-analysis and the trial data at prescriber.org.uk. [...]

]]> By: Trusted.MD Network http://www.prescriber.org.uk/2007/05/rosiglitazone-increases-cv-events/comment-page-1/#comment-1478 Trusted.MD Network Thu, 24 May 2007 12:19:39 +0000 http://www.prescriber.org.uk/?p=369#comment-1478 <strong>GSK - Avandia: MHRA advise patients</strong> GSK - Avandia: MHRA advise patients

]]>